PL3050877T3 - Pochodna aminy cyklicznej i jej farmaceutyczne zastosowanie - Google Patents

Pochodna aminy cyklicznej i jej farmaceutyczne zastosowanie

Info

Publication number
PL3050877T3
PL3050877T3 PL14849588T PL14849588T PL3050877T3 PL 3050877 T3 PL3050877 T3 PL 3050877T3 PL 14849588 T PL14849588 T PL 14849588T PL 14849588 T PL14849588 T PL 14849588T PL 3050877 T3 PL3050877 T3 PL 3050877T3
Authority
PL
Poland
Prior art keywords
amine derivative
pharmaceutical use
cyclic amine
cyclic
pharmaceutical
Prior art date
Application number
PL14849588T
Other languages
English (en)
Inventor
Yasuhiro Morita
Naoki Izumimoto
Katsuhiko Iseki
Shunsuke Iwano
Shuji UDAGAWA
Tomoya MIYOSHI
Yuji Osada
Tetsuro KOREEDA
Masanori Murakami
Motohiro Shiraki
Kei Takahashi
Keiyu OSHIDA
Original Assignee
Toray Industries, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries, Inc. filed Critical Toray Industries, Inc.
Publication of PL3050877T3 publication Critical patent/PL3050877T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41781,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/53771,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
PL14849588T 2013-09-26 2014-09-26 Pochodna aminy cyklicznej i jej farmaceutyczne zastosowanie PL3050877T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2013199853 2013-09-26
EP14849588.0A EP3050877B1 (en) 2013-09-26 2014-09-26 Cyclic amine derivative and pharmaceutical use thereof
PCT/JP2014/075569 WO2015046403A1 (ja) 2013-09-26 2014-09-26 環状アミン誘導体及びその医薬用途

Publications (1)

Publication Number Publication Date
PL3050877T3 true PL3050877T3 (pl) 2020-05-18

Family

ID=52743529

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14849588T PL3050877T3 (pl) 2013-09-26 2014-09-26 Pochodna aminy cyklicznej i jej farmaceutyczne zastosowanie

Country Status (17)

Country Link
US (1) US9505740B2 (pl)
EP (3) EP3050877B1 (pl)
JP (1) JP6409573B2 (pl)
KR (1) KR102276072B1 (pl)
CN (1) CN105555778B (pl)
AU (1) AU2014325146B2 (pl)
BR (1) BR112016006258B1 (pl)
CA (1) CA2924789C (pl)
DK (1) DK3050877T3 (pl)
ES (3) ES2829286T3 (pl)
HU (1) HUE046485T2 (pl)
MX (3) MX371281B (pl)
PL (1) PL3050877T3 (pl)
PT (1) PT3050877T (pl)
RU (1) RU2638549C2 (pl)
TW (1) TWI652264B (pl)
WO (1) WO2015046403A1 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3263565T3 (da) * 2015-02-27 2019-10-07 Toray Industries Cyklisk aminderivat og farmaceutisk anvendelse deraf
WO2016152955A1 (ja) * 2015-03-24 2016-09-29 東レ株式会社 環状アミン誘導体及びその医薬用途
MX2017011120A (es) * 2015-03-24 2017-11-28 Toray Industries Derivado de amina ciclica y uso farmaceutico del mismo.
JP6610793B2 (ja) 2016-08-26 2019-11-27 東レ株式会社 環状アミン誘導体の結晶及びその医薬用途
RU2770307C2 (ru) * 2017-03-31 2022-04-15 Торэй Индастриз, Инк. Терапевтическое или профилактическое средство против периферических невропатий
WO2021172488A1 (ja) * 2020-02-28 2021-09-02 東レ株式会社 環状アミン誘導体及びその医薬用途

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2163150B (en) 1984-07-19 1988-05-25 Sandoz Ltd 3-aminopropoxyaryl derivatives
JP2567885Y2 (ja) 1991-03-15 1998-04-08 ソニー株式会社 ビデオモニタ装置
GB0017256D0 (en) * 2000-07-13 2000-08-30 Merck Sharp & Dohme Therapeutic agents
EP1444219A1 (en) 2001-10-12 2004-08-11 Novo Nordisk A/S Substituted piperidines and their use for the treatment of diseases related to the histamine h3 receptor
NZ531679A (en) * 2001-10-15 2005-02-25 Janssen Pharmaceutica Nv Novel substituted 4-phenyl-4-[1H-imidazol-2-YL]-piperidine derivatives and their use as selective non-peptide delta opioid agonists
US7026312B2 (en) * 2002-03-14 2006-04-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Substituted piperidines, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof
EP1597256A1 (en) * 2003-02-21 2005-11-23 Pfizer Inc. N-heterocyclyl-substituted amino-thiazole derivatives as protein kinase inhibitors
CA2528096C (en) * 2003-06-17 2011-09-13 F. Hoffmann-La Roche Ag Cis-imidazolines as mdm2 inhibitors
US20050009841A1 (en) * 2003-07-11 2005-01-13 Zheng Guo Zhu Novel amides useful for treating pain
JP2006008664A (ja) 2004-05-21 2006-01-12 Takeda Chem Ind Ltd イミダゾール誘導体、その製造法及び用途
WO2008077089A1 (en) * 2006-12-19 2008-06-26 Smithkline Beecham Corporation Pyrrolidinanilines
US8299096B2 (en) * 2008-06-26 2012-10-30 Inspire Pharmaceuticals, Inc. Method for treating pulmonary diseases using rho kinase inhibitor compounds
WO2013147160A1 (ja) * 2012-03-29 2013-10-03 東レ株式会社 環状アミン誘導体及びその医薬用途

Also Published As

Publication number Publication date
AU2014325146B2 (en) 2018-01-18
EP3511002A1 (en) 2019-07-17
BR112016006258B1 (pt) 2023-01-10
TW201602093A (zh) 2016-01-16
EP3050877A4 (en) 2017-04-05
DK3050877T3 (da) 2020-01-27
ES2829286T3 (es) 2021-05-31
PT3050877T (pt) 2020-01-14
TWI652264B (zh) 2019-03-01
KR102276072B1 (ko) 2021-07-12
WO2015046403A1 (ja) 2015-04-02
EP3050877B1 (en) 2019-10-30
CA2924789C (en) 2021-06-22
CN105555778A (zh) 2016-05-04
RU2638549C2 (ru) 2017-12-14
EP3511003A1 (en) 2019-07-17
AU2014325146A1 (en) 2016-04-07
EP3511002B1 (en) 2020-08-19
ES2869136T3 (es) 2021-10-25
HUE046485T2 (hu) 2020-03-30
EP3050877A1 (en) 2016-08-03
EP3511003B1 (en) 2021-03-03
US9505740B2 (en) 2016-11-29
MX2019010487A (es) 2019-10-17
CN105555778B (zh) 2017-07-28
JPWO2015046403A1 (ja) 2017-03-09
MX2016003432A (es) 2016-06-30
RU2016116036A (ru) 2017-10-31
MX2019010485A (es) 2019-10-17
MX371281B (es) 2020-01-24
CA2924789A1 (en) 2015-04-02
BR112016006258A2 (pt) 2020-05-19
ES2759236T3 (es) 2020-05-08
JP6409573B2 (ja) 2018-10-24
KR102276072B9 (ko) 2021-09-06
US20160194302A1 (en) 2016-07-07
KR20160060034A (ko) 2016-05-27

Similar Documents

Publication Publication Date Title
IL240290B (en) History of pyridazinone-amide and pharmaceutical preparations containing them
IL240849B (en) Drug delivery devices and drug delivery method
ZA201705293B (en) Cyclic amine derivative and pharmaceutical use thereof
SG11201507327TA (en) Pyrazole-amide compound and medicinal uses therefor
IL260230B (en) A cyclic amine derivative and its medicinal use
IL244214A0 (en) Thienopiperidine derivative and its use
EP2968445A4 (en) NOVEL CYCLOSPORINE DERIVATIVES AND USES THEREOF
PL3064491T3 (pl) Pochodna sulfonamidowa i jej zastosowanie medyczne
ZA201507576B (en) Pharmaceutical combination drug
IL244751A0 (en) Cyclic thianouracil-carboxamides and their use
DK3079655T3 (da) Inhalerbare lægemidler
PT3050877T (pt) Derivado de amina cíclica e sua utilização farmacêutica
TWI562776B (en) Pharmaceutical composition and uses thereof
SG10201708778VA (en) Drug administering device and assembly method therefore
EP3275879A4 (en) Cyclic amine derivative and use thereof for medical purposes
IL244316A0 (en) A new composition of a drug
EP3275878A4 (en) Cyclic amine derivative and use thereof for medical purposes
PH32013001091S1 (en) Toothbrush and portions thereof
PH32013001020S1 (en) Toothbrush and portions thereof